back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-06-05 11:38 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-63,700 vol |
0 | |
| Filed 2024-06-05 11:38 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-232,268 vol |
0 | |
| Filed 2024-06-05 11:37 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-119,651 vol |
0 | |
| Filed 2024-06-05 11:37 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-955,544 vol |
0 | |
| Filed 2024-06-05 11:36 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Holder: Centre for Probe Development and Commercialization in trust for Eric Burak (Indirect Ownership)
|
Non-Voting Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-38,490 vol |
0 | |
| Filed 2024-03-12 15:31 Tx date 2022-02-01 |
$FUSN
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+168,200 vol |
599,444 | |
| Filed 2024-01-05 12:05 Tx date 2024-01-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+63,700 vol |
63,700 | |
| Filed 2024-01-05 12:05 Tx date 2020-06-25 |
$FUSN
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-05 12:04 Tx date 2024-01-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+106,100 vol |
787,344 | |
| Filed 2023-01-09 09:02 Tx date 2023-01-05 |
$FUSN
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
681,244 | |
| Filed 2021-02-08 19:03 Tx date 2021-02-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+136,600 vol |
431,244 | |
| Filed 2021-02-08 19:02 Tx date 2021-02-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+41,000 vol |
294,644 | |
| Filed 2021-02-08 19:00 Tx date 2021-02-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+139,000 vol |
253,644 | |
| Filed 2020-07-03 16:54 Tx date 2020-06-25 |
$
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
114,644 | ||
| Filed 2020-07-03 16:53 Tx date 2020-06-25 |
$
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
119,651 | ||
| Filed 2020-07-03 16:52 Tx date 2020-06-25 |
$
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
232,268 | ||
| Filed 2020-07-03 16:51 Tx date 2020-06-25 |
$
Fusion Pharmaceuticals Inc. |
Burak, Eric Steven
5 - Senior Officer of Issuer
Holder: Centre for Probe Development and Commercialization in trust for Eric Burak (Indirect Ownership)
|
Non-Voting Common Shares
00 - Opening Balance-Initial SEDI Report
|
38,490 |